Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107927162 | 10792716 | 2 | F | 20150115 | 20160712 | 20150213 | 20160718 | EXP | PHHO2015FR001226 | NOVARTIS | 61.00 | YR | F | Y | 0.00000 | 20160718 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 107927162 | 10792716 | 1 | PS | AFINITOR | EVEROLIMUS | 1 | Oral | 10 MG, QD | 22334 | 10 | MG | TABLET | QD | ||||||
| 107927162 | 10792716 | 2 | C | DIFFU-K | POTASSIUM CHLORIDE | 1 | Oral | 8 DF, QD | 0 | 8 | DF | CAPSULE | QD | ||||||
| 107927162 | 10792716 | 3 | C | LODOZ | BISOPROLOL FUMARATEHYDROCHLOROTHIAZIDE | 1 | Oral | 1 DF, QD (5MG/6.25MG) | 0 | 1 | DF | FILM-COATED TABLET | QD | ||||||
| 107927162 | 10792716 | 4 | C | OXYCONTIN | OXYCODONE HYDROCHLORIDE | 1 | Oral | 1 DF, QD (60 MG, 1 DF DAILY) | U | 0 | 1 | DF | FILM-COATED TABLET | QD | |||||
| 107927162 | 10792716 | 5 | C | CALCIDOSE VITAMINE D | CALCIUMCHOLECALCIFEROL | 1 | Oral | 2 DF, QD (500MG/400 IU) | 0 | 2 | DF | SACHET | BID | ||||||
| 107927162 | 10792716 | 6 | C | DIAMICRON | GLICLAZIDE | 1 | Oral | 60 MG | U | 0 | 60 | MG | TABLET | ||||||
| 107927162 | 10792716 | 7 | C | LEVOTHYROX | LEVOTHYROXINE | 1 | Unknown | 87.5 UG, QD | 0 | 87.5 | UG | QD | |||||||
| 107927162 | 10792716 | 8 | C | SANDOSTATIN | OCTREOTIDE ACETATE | 1 | Unknown | 120 MG, QMO | U | 0 | 120 | MG | POWDER FOR SOL FOR INJ | /month |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 107927162 | 10792716 | 1 | Metastases to liver |
| 107927162 | 10792716 | 2 | Product used for unknown indication |
| 107927162 | 10792716 | 3 | Product used for unknown indication |
| 107927162 | 10792716 | 4 | Product used for unknown indication |
| 107927162 | 10792716 | 5 | Product used for unknown indication |
| 107927162 | 10792716 | 6 | Product used for unknown indication |
| 107927162 | 10792716 | 7 | Product used for unknown indication |
| 107927162 | 10792716 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 107927162 | 10792716 | DS |
| 107927162 | 10792716 | DE |
| 107927162 | 10792716 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 107927162 | 10792716 | Anaemia | |
| 107927162 | 10792716 | Death | |
| 107927162 | 10792716 | Hepatic cirrhosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 107927162 | 10792716 | 1 | 20140206 | 20150116 | 0 | |
| 107927162 | 10792716 | 4 | 201411 | 0 | ||
| 107927162 | 10792716 | 6 | 20150116 | 0 |